Apta Health – Trademark Portfolio

Entity Type: 16

Apta Health has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include APTA HEALTH. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 36 (Insurance & Financial). This trademark owner is based in Englewood, CO.

11755 E. Peakview Ave. #250

Englewood, CO 80111

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Apta Health's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Apta Health have?

Apta Health has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Apta Health file in?

Apta Health files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are Apta Health's most well-known trademarks?

Apta Health's registered trademark portfolio includes well-known marks such as APTA HEALTH. These are among 1 currently registered trademark in the portfolio.

What is Apta Health's trademark registration success rate?

Apta Health has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.